Prenetics Global Limited (NASDAQ: PRE)
$6.00
-0.1700 ( -2.76% ) 3.4K
Prenetics Global Ltd is a genomics-driven health sciences company, that is revolutionizing prevention, early detection, and treatment. The company's prevention arm, CircleDNA, uses whole exome sequencing to offer comprehensive consumer DNA tests. Insighta, Its joint venture with scientist Prof. Dennis Lo, underscores the company's unwavering commitment to saving lives through pioneering multi-cancer early detection technologies. Lastly, ACT Genomics, its treatment unit, is the first Asia-based company to achieve FDA clearance for comprehensive genomic profiling of solid tumors via ACTOnco. Each of Prenetics' units synergistically enhances its global impact on health, truly embodying Prenetics commitment to 'enhancing life through science'.
Market Data
Open
$6.00
Previous close
$6.17
Volume
3.4K
Market cap
$73.79M
Day range
$5.97 - $6.22
52 week range
$2.85 - $13.28
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k/a | Quarterly Reports | 7 | Jul 11, 2024 |
6-k | Quarterly Reports | 23 | Jul 11, 2024 |
6-k | Quarterly Reports | 3 | Jul 01, 2024 |
6-k | Quarterly Reports | 5 | Jun 18, 2024 |
6-k | Quarterly Reports | 3 | May 21, 2024 |
6-k | Quarterly Reports | 3 | May 20, 2024 |
20-f | Annual reports | 199 | May 01, 2024 |
6-k | Quarterly Reports | 5 | Apr 01, 2024 |
6-k | Quarterly Reports | 3 | Mar 25, 2024 |
20-f | Annual reports | 152 | Mar 25, 2024 |